Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08ICI
|
|||
| Former ID |
DNC008113
|
|||
| Drug Name |
N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)
|
|||
| Synonyms |
CHEMBL402990; N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H13NO5
|
|||
| Canonical SMILES |
COC1=CC2=C(C=C1)OC(=O)C(=C2)CCC(=O)NO
|
|||
| InChI |
1S/C13H13NO5/c1-18-10-3-4-11-9(7-10)6-8(13(16)19-11)2-5-12(15)14-17/h3-4,6-7,17H,2,5H2,1H3,(H,14,15)
|
|||
| InChIKey |
JUDXBTMVZVWJNP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation. Bioorg Med Chem. 2008 Jan 1;16(1):530-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.